View Past PerformanceIDEX Biometrics 대차대조표 건전성재무 건전성 기준 점검 3/6IDEX Biometrics 의 총 주주 지분은 NOK-6.0M 이고 총 부채는 NOK0.0, 이는 부채 대 자기자본 비율을 0% 로 가져옵니다. 총자산과 총부채는 각각 NOK75.4M 및 NOK81.4M 입니다.핵심 정보0%부채/자본 비율NOK 0부채이자보상배율n/a현금NOK 1.38m자본-NOK 5.97m총부채NOK 81.40m총자산NOK 75.43m최근 재무 건전성 업데이트업데이트 없음모든 업데이트 보기Recent updatesNew Risk • 1hNew major risk - Negative shareholders equityThe company has negative equity. Total equity: -kr6.0m This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Negative equity (-kr6.0m). Shareholders have been substantially diluted in the past year (74% increase in shares outstanding). Revenue is less than US$1m (kr3.1m revenue, or US$317k). Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Market cap is less than US$100m (€57.1m market cap, or US$64.9m).Board Change • Jun 10High number of new directorsExecutive Chairman of the Board Anders Storbraten was the last director to join the board, commencing their role in 2026.공시 • Jun 05IDEX Biometrics ASA has filed a Follow-on Equity Offering in the amount of NOK 20.625 million.IDEX Biometrics ASA has filed a Follow-on Equity Offering in the amount of NOK 20.625 million. Security Name: Shares Security Type: Common Stock Securities Offered: 2,500,000 Price\Range: NOK 8.25 Transaction Features: Subsequent Direct Listing공시 • May 30IDEX Biometrics ASA has withdrawn its Follow-on Equity Offering in the amount of NOK 19.999997 million.IDEX Biometrics ASA has withdrawn its Follow-on Equity Offering in the amount of NOK 19.999997 million. Security Name: Shares Security Type: Common Stock Securities Offered: 2,424,242 Price\Range: NOK 8.25 Transaction Features: Rights Offering공시 • Apr 29IDEX Biometrics ASA has filed a Follow-on Equity Offering in the amount of NOK 19.999997 million.IDEX Biometrics ASA has filed a Follow-on Equity Offering in the amount of NOK 19.999997 million. Security Name: Shares Security Type: Common Stock Securities Offered: 2,424,242 Price\Range: NOK 8.25 Transaction Features: Rights Offering공시 • Mar 06IDEX Biometrics ASA announced that it expects to receive NOK 90.000001 million in fundingIDEX Biometrics ASA announced a private placement to issue NOK 90,000,000 to ID centric in two tranches on March 5, 2026.The first tranche with 3,824,233 new shares at a price of NOK 5.83 per share for gross proceeds of NOK 2,2295,278.39 and it is getting closed on the same day. The second tranche with 11,613,159.795883 at a price of NOK 5.83 per share for gross proceeds of NOK 67,704,721.609998. The first tranche has been approved by the board of directors and an extraordinary general meeting will be held on or about March 27, 2026 to seek the necessary approval for the second tranche.공시 • Jan 02IDEX Biometrics ASA, Annual General Meeting, May 21, 2026IDEX Biometrics ASA, Annual General Meeting, May 21, 2026.공시 • Dec 31+ 3 more updatesIDEX Biometrics ASA to Report First Half, 2026 Results on Aug 20, 2026IDEX Biometrics ASA announced that they will report first half, 2026 results on Aug 20, 2026공시 • Dec 05+ 1 more updateIDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 21.999999 million.IDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 21.999999 million. Security Name: Shares Security Type: Common Stock Securities Offered: 5,690,970 Price\Range: NOK 3 Security Name: Shares Security Type: Common Stock Securities Offered: 1,642,363 Price\Range: NOK 3 Transaction Features: Rule 144A; Subsequent Direct Listing공시 • Sep 27Reserve Bank of India Approves Biometric Payment Authentication TechnologyReserve Bank of India (RBI) has approved biometric authentication technology for digital payments, including IDEX's fingerprint payment solutions, through new authentication mechanisms for digital payment transactions directions effective April 2026. The RBI mandate specifically endorses fingerprint biometric authentication as an approved method for India's digital payment ecosystem, moving beyond traditional SMS-based one-time passwords. This regulatory approval validates IDEX's strategic positioning in the Indian market. The IDEX Pay solution performs biometric authentication directly on the payment card without requiring infrastructure changes to existing merchant terminals. The technology ensures biometric data remains encrypted and stored exclusively on the card, addressing the RBI's enhanced security requirements while maintaining user privacy.공시 • Sep 12IDEX Biometrics ASA Launches New Product Portfolio for Payment and Access SolutionsIDEX Biometrics ASA announced the launch of its new product portfolio for payment and access solutions, accompanied by a redesigned website showcasing the company's advanced biometric authentication offerings. This launch marks a key milestone in the company's strategic transformation and delivery on previously communicated commitments.재무 상태 분석단기부채: I8X 에는 음의 주주 지분이 있는데, 이는 단기 부채를 감당하지 못하는 단기 자산보다 더 심각한 상황입니다.장기 부채: I8X는 마이너스 주주 지분을 갖고 있어 장기 부채를 충당하지 못하는 단기 자산보다 더 심각한 상황입니다.부채/자본 비율 추이 및 분석부채 수준: I8X 부채가 없습니다.부채 감소: I8X는 주주 지분이 음수이므로 부채가 시간이 지남에 따라 감소했는지 확인할 필요가 없습니다.대차대조표현금 보유 기간 분석과거에 평균적으로 손실을 기록해 온 기업의 경우, 최소 1년 이상의 현금 보유 기간이 있는지 평가합니다.안정적인 현금 활주로: I8X 은 마지막 보고 무료 현금 흐름을 기준으로 0 개월 동안 충분한 현금 활주로를 보유하고 있지만 이후 추가 자본을 조달했다.예측 현금 활주로: I8X 은 잉여현금흐름추정을 기준으로 0 개월 동안 충분한 현금 활주로를 확보할 것으로 예상되지만 이후 추가 자본을 조달했습니다.건전한 기업 찾아보기7D1Y7D1Y7D1YTech 산업의 건실한 기업.View Dividend기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/25 23:10종가2026/06/25 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스IDEX Biometrics ASA는 5명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Hans Rettedal ChristiansenCarnegie Investment Bank ABJonas LisauskasNorne Securities ASAuguste RichardNorthland Capital Markets2명의 분석가 더 보기
New Risk • 1hNew major risk - Negative shareholders equityThe company has negative equity. Total equity: -kr6.0m This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Negative equity (-kr6.0m). Shareholders have been substantially diluted in the past year (74% increase in shares outstanding). Revenue is less than US$1m (kr3.1m revenue, or US$317k). Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Market cap is less than US$100m (€57.1m market cap, or US$64.9m).
Board Change • Jun 10High number of new directorsExecutive Chairman of the Board Anders Storbraten was the last director to join the board, commencing their role in 2026.
공시 • Jun 05IDEX Biometrics ASA has filed a Follow-on Equity Offering in the amount of NOK 20.625 million.IDEX Biometrics ASA has filed a Follow-on Equity Offering in the amount of NOK 20.625 million. Security Name: Shares Security Type: Common Stock Securities Offered: 2,500,000 Price\Range: NOK 8.25 Transaction Features: Subsequent Direct Listing
공시 • May 30IDEX Biometrics ASA has withdrawn its Follow-on Equity Offering in the amount of NOK 19.999997 million.IDEX Biometrics ASA has withdrawn its Follow-on Equity Offering in the amount of NOK 19.999997 million. Security Name: Shares Security Type: Common Stock Securities Offered: 2,424,242 Price\Range: NOK 8.25 Transaction Features: Rights Offering
공시 • Apr 29IDEX Biometrics ASA has filed a Follow-on Equity Offering in the amount of NOK 19.999997 million.IDEX Biometrics ASA has filed a Follow-on Equity Offering in the amount of NOK 19.999997 million. Security Name: Shares Security Type: Common Stock Securities Offered: 2,424,242 Price\Range: NOK 8.25 Transaction Features: Rights Offering
공시 • Mar 06IDEX Biometrics ASA announced that it expects to receive NOK 90.000001 million in fundingIDEX Biometrics ASA announced a private placement to issue NOK 90,000,000 to ID centric in two tranches on March 5, 2026.The first tranche with 3,824,233 new shares at a price of NOK 5.83 per share for gross proceeds of NOK 2,2295,278.39 and it is getting closed on the same day. The second tranche with 11,613,159.795883 at a price of NOK 5.83 per share for gross proceeds of NOK 67,704,721.609998. The first tranche has been approved by the board of directors and an extraordinary general meeting will be held on or about March 27, 2026 to seek the necessary approval for the second tranche.
공시 • Jan 02IDEX Biometrics ASA, Annual General Meeting, May 21, 2026IDEX Biometrics ASA, Annual General Meeting, May 21, 2026.
공시 • Dec 31+ 3 more updatesIDEX Biometrics ASA to Report First Half, 2026 Results on Aug 20, 2026IDEX Biometrics ASA announced that they will report first half, 2026 results on Aug 20, 2026
공시 • Dec 05+ 1 more updateIDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 21.999999 million.IDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 21.999999 million. Security Name: Shares Security Type: Common Stock Securities Offered: 5,690,970 Price\Range: NOK 3 Security Name: Shares Security Type: Common Stock Securities Offered: 1,642,363 Price\Range: NOK 3 Transaction Features: Rule 144A; Subsequent Direct Listing
공시 • Sep 27Reserve Bank of India Approves Biometric Payment Authentication TechnologyReserve Bank of India (RBI) has approved biometric authentication technology for digital payments, including IDEX's fingerprint payment solutions, through new authentication mechanisms for digital payment transactions directions effective April 2026. The RBI mandate specifically endorses fingerprint biometric authentication as an approved method for India's digital payment ecosystem, moving beyond traditional SMS-based one-time passwords. This regulatory approval validates IDEX's strategic positioning in the Indian market. The IDEX Pay solution performs biometric authentication directly on the payment card without requiring infrastructure changes to existing merchant terminals. The technology ensures biometric data remains encrypted and stored exclusively on the card, addressing the RBI's enhanced security requirements while maintaining user privacy.
공시 • Sep 12IDEX Biometrics ASA Launches New Product Portfolio for Payment and Access SolutionsIDEX Biometrics ASA announced the launch of its new product portfolio for payment and access solutions, accompanied by a redesigned website showcasing the company's advanced biometric authentication offerings. This launch marks a key milestone in the company's strategic transformation and delivery on previously communicated commitments.